This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Syndrome X (angina)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Cardiac syndrome x

  • term syndrome x is used to describe the combination of angina-like chest pain, positive objective evidence of myocardial ischaemia (eg radionucleide perfusion scan) with a normal coronary angiogram

  • seen most frequently in women often in the early menopausal years

  • cause of syndrome x is not established but it may be due to abnormal endothelial function in small, resistance coronary arteries. This is in contrast to established CHD where myocardial ischaemia occurs due to obstruction of coronary blood flow by atherosclerotic plaques

  • treatment for syndrome x is focused on symptom control with beta blockers or calcium channel blockers as first line. Overall the prognosis is more favourable than for those with obstructive coronary disease

NICE state with respect to Cardiac syndrome X:

  • in people with angiographically normal coronary arteries and continuing anginal symptoms, consider a diagnosis of cardiac syndrome X.
  • continue drug treatment for stable angina only if it improves the symptoms of the person with suspected cardiac syndrome X
  • do not routinely offer drugs for the secondary prevention of cardiovascular disease to people with suspected cardiac syndrome X.

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.